Current status of malaria elimination in Koraput district of Odisha, India.

BACKGROUND & OBJECTIVES: After launching of NFME and NSP with wide scale implementation of effective intervention tools during 2017, Odisha State of India observed a drastic reduction of malaria cases (81%) in 2018 and 88.6% in 2019, compared to 2017. The current study analysed the different factors causative for malaria reduction in Koraput district of Odisha State, India. METHODS: The vector density and malaria incidences were assessed from January 2016 to December 2019 and human blood index, bio-efficacy and use rate of LLINs were assessed after distribution of long-lasting insecticidal nets. RESULTS: The use rate of LLINs by the villagers ranged from 93.8% to 100% throughout the year. The mortality of Anopheles jeyporiensis remained 100.0% in both DuraNet and PermaNet LNs. The density of An. fluviatilis after distribution of LLINs reduced from 4.7 to 0.0 whereas, the density of An. culicifacies reduced from 12.2 to 9.3. The HBI of An. fluviatilis and An. culicifacies was 0.006 and 0.005, respectively after distribution of LLINs. The malaria incidences also drop from 14.2 to zero after distribution. INTERPRETATION & CONCLUSION: A significant reduction in malaria incidences was validated and the possible reasons for the reduction are discussed.

Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory Infections.

Nasal sprays for pre-exposure prophylaxis against respiratory infections show limited protection (20-70%), largely due to their single mechanism of action-either neutralizing pathogens or blocking their entry at the nasal lining, and a failure to maximize the capture of respiratory droplets, allowing them to potentially rebound and reach deeper airways. This report introduces the Pathogen Capture and Neutralizing Spray (PCANS), which utilizes a multi-modal approach to enhance efficacy. PCANS coats the nasal cavity, capturing large respiratory droplets from the air, and serving as a physical barrier against a broad spectrum of viruses and bacteria, while rapidly neutralizing them with over 99.99% effectiveness. The formulation consists of excipients identified from the FDA's Inactive Ingredient Database and Generally Recognized as Safe list to maximize efficacy for each step in the multi-modal approach. PCANS demonstrates nasal retention for up to 8 hours in mice. In a severe Influenza A mouse model, a single pre-exposure dose of PCANS leads to a >99.99% reduction in lung viral titer and ensures 100% survival, compared to 0% in the control group. PCANS suppresses pathological manifestations and offers protection for at least 4 hours. This data suggest PCANS as a promising daily-use prophylactic against respiratory infections.

Role of bioaerosol in virus transmission and material-based countermeasures.

Respiratory pathogens transmit primarily through particles such as droplets and aerosols. Although often overlooked, the resuspension of settled droplets is also a key facilitator of disease transmission. In this review, we discuss the three main mechanisms of aerosol generation: direct generation such as coughing and sneezing, indirect generation such as medical procedures, and resuspension of settled droplets and aerosols. The size of particles and environmental factors influence their airborne lifetime and ability to cause infection. Specifically, humidity and temperature are key factors controlling the evaporation of suspended droplets, consequently affecting the duration in which particles remain airborne. We also suggest material-based approaches for effective prevention of disease transmission. These approaches include electrostatically charged virucidal agents and surface coatings, which have been shown to be highly effective in deactivating and reducing resuspension of pathogen-laden aerosols.